Clock.Bio
Cambridge, United Kingdom · Founded 2023 · $5.3M raised
- Headquarters
- Cambridge
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- clock.bio
- Total Funding
- $5.3M
- Last Round
- $5.3M SeedOct 2024
- Rounds
- 1
About
clock.bio is a rejuvenation biology company developing therapies to extend human healthspan by reversing cellular aging at the genetic level. Using proprietary CRISPR screens in human induced pluripotent stem cells, the company has mapped over 150 genes in its 'geneAge Atlas of Rejuvenation Factors' and built an AI-powered cell age measurement platform called imAge. Based at the Milner Therapeutics Institute, University of Cambridge, the company raised $5.3M in seed funding in 2024.
Summary
Clock.Bio is a Biotech company based in Cambridge, United Kingdom, founded in 2023. It has raised $5.3M in total across 1 round, most recently a $5.3M Seed round in Oct 2024. Investors include LocalGlobe and BlueYard Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2024
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...